Cell-Free DNA (cfDNA) Testing Market To Reach USD 22.41 Billion By 2027 | Industry Trend – Rise in the Use of Cell-Free DNA to Treat Chromosomal Disorders

The global Cell-Free DNA (cfDNA) Testing Market is forecasted to be worth USD 22.41 Billion by 2027, according to a new report by Emergen Research. The global Cell-Free DNA (cfDNA) testing market is expected to grow significantly during the forecast period due to the increased incidence of cancers, rising prevalence of chromosome abnormalities in babies due to an increasing number of late pregnancy, and growing demand for non-invasive testing procedures. Besides, the increasing investments by governments to implement advanced therapeutic technology in hospitals is also expected to boost the market during the forecast period.

Due to its ability to provide highly accurate single-molecule counting and identification of minor variations in the number of sequences of blood concentration on the chromosome, cell-free foetal DNA research segment is receiving increased interest and investments.

On the other hand, due to its ability to sequence DNA molecules on as many as one million or more Megaclone beads at the same time, the MPSS technology is expected to more widely adopted over the forecast period.

Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample-form/156

Key Highlights From The Report:

  • By type the cell-free foetal DNA (NIPT) segment accounted for the largest market share of 48.8 percent in 2019.
  • On the basis of technology the MPSS segment, with a 45.8% share in 2019, dominated the market.
  • On the basis of application, the gynaecology segment is expected to dominate the market during the forecast period. By 2027, the segment revenue is expected to surpass USD 10.55 billion.
  • With a share of 33.6% North America held the largest market share in 2019 in in the Cell-Free DNA (cfDNA) testing market.
  • Due to the growing investment by governments to build hospital infrastructure along with the introduction of advanced therapeutic technology, the Asia Pacific Cell-Free DNA (cfDNA) testing market is expected to experience steady growth over the forecast period.
  • Sequenom, Inc., Quest Diagnostics, Illumina Inc., Agilent Technologies, Inc., Guardant Health, Inc., Biodesix, Inc., Allenex AB, Roche Holdings AG, Biocept, Inc., CareDx, Inc. are some of the participants in the cell-free DNA (cfDNA) testing market.
  • In September 2020, Illumina Inc., a biotechnology company, signed a final agreement to acquire Grail Inc., a manufacturer of multi-cancer blood test equipment. With the inclusion of cancer screening, diagnostic, and cancer monitoring systems, this acquisition will expand the Illumina product range.
  • Guardant Health acquired Bellwether Bio in March 2019. This deal was intended to enable Guardant Health to broaden the oncology segment's product range. With the help of Bellwether Bio, Guardant Health is planning to develop a technique for primary blood-based cancer detection that relies on the detection of gene signs in circulating cell-free DNA.

Check Our Prices@ https://www.emergenresearch.com/select-license/156

 

Emergen Research has segmented the global cell-free DNA (cfDNA) testing market based on type, technology, application, and region:

  • Type Outlook (Revenue, USD Billion; 2017-2027)
    • Cell-free fetal DNA (NIPT)
    • Circulating tumor DNA
    • Donor-derived cell-free DNA
  • Technology Outlook (Revenue, USD Billion; 2017-2027)
    • MPSS
    • t-MPS
    • SNP
    • Others
  • Application Outlook (Revenue, USD Billion; 2017-2027)
    • Transplantation
    • Gynecology
    • Oncology

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends:   https://www.emergenresearch.com/industry-report/cell-free-dna-market

  • Regional Outlook (Revenue, USD Billion; 2017-2027)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. India
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. U.A.E.
      3. Rest of MEA

Table of Content

Chapter 1. Methodology & Sources

    1.1. Market Definition

    1.2. Research Scope 

    1.3. Methodology

    1.4. Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

    1.5. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2020-2030

Chapter 3. Key Insights

Chapter 4. Cell-Free DNA (cfDNA) Testing Market Segmentation & Impact Analysis

    4.1. Cell-Free DNA (cfDNA) Testing Market Material Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers’ analysis

          4.2.3. Market restraints analysis

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. Porter’s Five Forces Analysis

    4.6. Competitive Metric Space Analysis

    4.7. Price trend Analysis

    4.8. Covid-19 Impact Analysis

Continued…

 

Insights into our Other Published Healthcare Reports:

Metaverse in Finance Market By Component (Hardware, Software), Technology (Blockchain, Metaverse Wallets, Virtual Assistants, NFT), End Use (Brokerage Firms, Investment Banks, Financial Institutions, Fintech Companies, Digital Asset Management Companies, Financial Advisory Companies, Commercial Banks), and By Region Forecast.

Digital Human Avatar Market By Product Type, By Industry Vertical, and By Region Forecast to 2030.

Metaverse in Manufacturing Market By Component (Hardware, Software), By Technology (AR, VR, MR, IoT, AI), By Application (Supply Chain Management, Product Designing and Development, Factory Landscape, Virtual Warehouse, Others), By End Use Industries (Automotive, Electronics, Manufacturing, Design Companies, Textile, Logistics Providers, Others), and by Region Forecast to 2028.

Nano Satellite Market Size, Share, Trends, By Mass (1kg-3kg, 4kg-6kg, and 7kg-10kg), By Application (Communication, Scientific Research, and others), By End-use, and By Region Forecast to 2030.

Graph Database Market By Component (Solution, Service), By Deployment (On-premise, Cloud), By Graph Type, By Organization Size, By Analysis Type, By Application, By End-Use, and By Region Forecast to 2030.

Data Visualization Market Size, Share, Trends, By Component (Software, Service, Solution), By Deployment (Cloud and On-Premises), By Enterprise (Small, Medium, Large), By End Use (Healthcare, Education, Government), and By Region Forecast

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkedIn | Twitter | Blogs

Read Our Press Release@ https://www.emergenresearch.com/press-release/global-cell-free-dna-market

 

 

Back to news